Title |
ZNF300, a recently identified human transcription factor, activates the human IL-2Rβ promoter through the overlapping ZNF300/EGR1 binding site
|
---|---|
Published in |
Cellular & Molecular Biology Letters, June 2010
|
DOI | 10.2478/s11658-010-0025-1 |
Pubmed ID | |
Authors |
Lu Xue, Hongling Qiu, Jian Ma, Mingxiong Guo, Wenxin Li |
Abstract |
ZNF300 was recently identified as a member of the human KRAB/C(2)H(2) zinc finger protein family. Little is known about the role of ZNF300 in human gene regulation networks. In this study, the DNA-binding property of ZNF300 was further analyzed. We found that the recombinant ZNF300 could bind to the binding site 5'-GCGGGGGCG-3' of Egr1, another member of the KRAB/C(2)H(2) zinc finger protein family. Similarly, recombinant Egr1 also showed a similar binding affinity to the ZNF300 binding site 5'-CTGGGGGCG-3'. Bioinformatics analysis revealed that there is an overlapping ZNF300/Egr1 binding site in the human IL-2Rβ promoter region, which was previously known to be recognized by endogenous Egr1. Electrophoretic mobility shift assays showed that endogenous ZNF300 could also bind to this site. A transient transfection assay revealed that both ZNF300 and Egr1 could transactivate the IL-2Rβ promoter, and that the activation was abrogated by a mutation of residues in the overlapping ZNF300/Egr1 binding site. Co-expression of ZNF300 and Egr1 led to enhanced IL-2Rβ promoter activity. Thus, ZNF300 is likely to be another regulator of the human IL-2Rβ promoter. |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
Iran, Islamic Republic of | 1 | 10% |
Brazil | 1 | 10% |
Unknown | 8 | 80% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Researcher | 3 | 30% |
Student > Ph. D. Student | 3 | 30% |
Other | 1 | 10% |
Student > Doctoral Student | 1 | 10% |
Student > Master | 1 | 10% |
Other | 1 | 10% |
Readers by discipline | Count | As % |
---|---|---|
Agricultural and Biological Sciences | 6 | 60% |
Biochemistry, Genetics and Molecular Biology | 2 | 20% |
Economics, Econometrics and Finance | 1 | 10% |
Medicine and Dentistry | 1 | 10% |